Computational identification of Shenshao Ningxin Yin as an effective treatment for novel coronavirus infection (COVID-19) with myocarditis

Background: The newly identified betacoronavirus SARS-CoV-2 is the causative pathogen of the 2019 coronavirus disease (COVID-19), which has killed more than 4.5 million people. SARS-CoV-2 causes severe respiratory distress syndrome by targeting the lungs and also induces myocardial damage. Shenshao...

Full description

Bibliographic Details
Main Authors: Ze-Yu Zhang, Zhu-Jun Mao, Ye-ping Ruan, Xin Zhang
Format: Article
Language:English
Published: AIMS Press 2022-04-01
Series:Mathematical Biosciences and Engineering
Subjects:
Online Access:https://www.aimspress.com/article/doi/10.3934/mbe.2022270?viewType=HTML
_version_ 1818273026502819840
author Ze-Yu Zhang
Zhu-Jun Mao
Ye-ping Ruan
Xin Zhang
author_facet Ze-Yu Zhang
Zhu-Jun Mao
Ye-ping Ruan
Xin Zhang
author_sort Ze-Yu Zhang
collection DOAJ
description Background: The newly identified betacoronavirus SARS-CoV-2 is the causative pathogen of the 2019 coronavirus disease (COVID-19), which has killed more than 4.5 million people. SARS-CoV-2 causes severe respiratory distress syndrome by targeting the lungs and also induces myocardial damage. Shenshao Ningxin Yin (SNY) has been used for more than 700 years to treat influenza. Previous randomized controlled trials (RCTs) have demonstrated that SNY can improve the clinical symptoms of viral myocarditis, reverse arrhythmia, and reduce the level of myocardial damage markers. Methods: This work uses a rational computational strategy to identify existing drug molecules that target host pathways for the treatment of COVID-19 with myocarditis. Disease and drug targets were input into the STRING database to construct proteinɃprotein interaction networks. The Metascape database was used for GO and KEGG enrichment analysis. Results: SNY signaling modulated the pathways of coronavirus disease, including COVID-19, Ras signaling, viral myocarditis, and TNF signaling pathways. Tumor necrosis factor (TNF), cellular tumor antigen p53 (TP53), mitogen-activated protein kinase 1 (MAPK1), and the signal transducer and activator of transcription 3 (STAT3) were the pivotal targets of SNY. The components of SNY bound well with the pivotal targets, indicating there were potential biological activities. Conclusion: Our findings reveal the pharmacological role and molecular mechanism of SNY for the treatment of COVID-19 with myocarditis. We also, for the first time, demonstrate that SNY displays multi-component, multi-target, and multi-pathway characteristics with a complex mechanism of action.
first_indexed 2024-12-12T21:51:25Z
format Article
id doaj.art-59c7eb9100ea46c2b8e2a49912a6eae3
institution Directory Open Access Journal
issn 1551-0018
language English
last_indexed 2024-12-12T21:51:25Z
publishDate 2022-04-01
publisher AIMS Press
record_format Article
series Mathematical Biosciences and Engineering
spelling doaj.art-59c7eb9100ea46c2b8e2a49912a6eae32022-12-22T00:10:46ZengAIMS PressMathematical Biosciences and Engineering1551-00182022-04-011965772579210.3934/mbe.2022270Computational identification of Shenshao Ningxin Yin as an effective treatment for novel coronavirus infection (COVID-19) with myocarditisZe-Yu Zhang0Zhu-Jun Mao1Ye-ping Ruan2Xin Zhang31. School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China1. School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China 2. Chinese Medicine Plant Essential Oil Zhejiang Engineering Research Center, Zhejiang Chinese Medical University, Hangzhou 310053, China1. School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China 2. Chinese Medicine Plant Essential Oil Zhejiang Engineering Research Center, Zhejiang Chinese Medical University, Hangzhou 310053, China1. School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China 2. Chinese Medicine Plant Essential Oil Zhejiang Engineering Research Center, Zhejiang Chinese Medical University, Hangzhou 310053, ChinaBackground: The newly identified betacoronavirus SARS-CoV-2 is the causative pathogen of the 2019 coronavirus disease (COVID-19), which has killed more than 4.5 million people. SARS-CoV-2 causes severe respiratory distress syndrome by targeting the lungs and also induces myocardial damage. Shenshao Ningxin Yin (SNY) has been used for more than 700 years to treat influenza. Previous randomized controlled trials (RCTs) have demonstrated that SNY can improve the clinical symptoms of viral myocarditis, reverse arrhythmia, and reduce the level of myocardial damage markers. Methods: This work uses a rational computational strategy to identify existing drug molecules that target host pathways for the treatment of COVID-19 with myocarditis. Disease and drug targets were input into the STRING database to construct proteinɃprotein interaction networks. The Metascape database was used for GO and KEGG enrichment analysis. Results: SNY signaling modulated the pathways of coronavirus disease, including COVID-19, Ras signaling, viral myocarditis, and TNF signaling pathways. Tumor necrosis factor (TNF), cellular tumor antigen p53 (TP53), mitogen-activated protein kinase 1 (MAPK1), and the signal transducer and activator of transcription 3 (STAT3) were the pivotal targets of SNY. The components of SNY bound well with the pivotal targets, indicating there were potential biological activities. Conclusion: Our findings reveal the pharmacological role and molecular mechanism of SNY for the treatment of COVID-19 with myocarditis. We also, for the first time, demonstrate that SNY displays multi-component, multi-target, and multi-pathway characteristics with a complex mechanism of action.https://www.aimspress.com/article/doi/10.3934/mbe.2022270?viewType=HTMLshenshao ningxin yin (sny)novel coronavirus infection (covid-19)myocarditisnetwork pharmacologymolecular dockingsars-cov-2
spellingShingle Ze-Yu Zhang
Zhu-Jun Mao
Ye-ping Ruan
Xin Zhang
Computational identification of Shenshao Ningxin Yin as an effective treatment for novel coronavirus infection (COVID-19) with myocarditis
Mathematical Biosciences and Engineering
shenshao ningxin yin (sny)
novel coronavirus infection (covid-19)
myocarditis
network pharmacology
molecular docking
sars-cov-2
title Computational identification of Shenshao Ningxin Yin as an effective treatment for novel coronavirus infection (COVID-19) with myocarditis
title_full Computational identification of Shenshao Ningxin Yin as an effective treatment for novel coronavirus infection (COVID-19) with myocarditis
title_fullStr Computational identification of Shenshao Ningxin Yin as an effective treatment for novel coronavirus infection (COVID-19) with myocarditis
title_full_unstemmed Computational identification of Shenshao Ningxin Yin as an effective treatment for novel coronavirus infection (COVID-19) with myocarditis
title_short Computational identification of Shenshao Ningxin Yin as an effective treatment for novel coronavirus infection (COVID-19) with myocarditis
title_sort computational identification of shenshao ningxin yin as an effective treatment for novel coronavirus infection covid 19 with myocarditis
topic shenshao ningxin yin (sny)
novel coronavirus infection (covid-19)
myocarditis
network pharmacology
molecular docking
sars-cov-2
url https://www.aimspress.com/article/doi/10.3934/mbe.2022270?viewType=HTML
work_keys_str_mv AT zeyuzhang computationalidentificationofshenshaoningxinyinasaneffectivetreatmentfornovelcoronavirusinfectioncovid19withmyocarditis
AT zhujunmao computationalidentificationofshenshaoningxinyinasaneffectivetreatmentfornovelcoronavirusinfectioncovid19withmyocarditis
AT yepingruan computationalidentificationofshenshaoningxinyinasaneffectivetreatmentfornovelcoronavirusinfectioncovid19withmyocarditis
AT xinzhang computationalidentificationofshenshaoningxinyinasaneffectivetreatmentfornovelcoronavirusinfectioncovid19withmyocarditis